Correction: Cisplatin-Induced Epigenetic Activation of miR-34a Sensitizes Bladder Cancer Cells to Chemotherapy

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status

International Journal of Cancer
Cancer ResearchOncology
2011English

Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin-Induced Apoptosis

Cancer Studies and Molecular Medicine - Open Journal
2015English

Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy

Oncotarget
Oncology
2016English

Reactivation of Epigenetically Silenced miR-512 and miR-373 Sensitizes Lung Cancer Cells to Cisplatin and Restricts Tumor Growth

Cell Death and Differentiation
Cell BiologyMolecular Biology
2015English

Genistein Sensitizes Cancer Cells to Chemotherapy: Table 1.

Cancer Research
Cancer ResearchOncology
2005English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2018English

miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy